UBS Maintains Buy on Albemarle, Lowers Price Target to $150
UBS analyst Joshua Spector maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $175 to $150.
Stocks · News reference
Trump’s $500M critical minerals push targets lithium, refining and battery recycling. Here are 3 ETFs positioned for the U.S. reshoring boom.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Joshua Spector maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $175 to $150.
The global microporous materials market is projected to grow from $5.9 billion in 2024 to $7.2 billion by 2030, expanding at a 3.2% CAGR. Growth is driven by rising demand for carbon capture, clean fuels, purification, and advanced manufacturing applications. Key players including BASF, Honeywell UOP, Albemarle, and Evonik are accelerating development of metal-organic frameworks (MOFs) and carbon-capture technologies. Asia-Pacific, particularly China, is expected to see strong growth at 5.8% CAGR.
Stocks related to Greenland surged after the new U.S.-Greenland deal. Here’s what it could mean for rare-earth and critical-minerals ETFs.
The Department of Energy announced a $4.2 billion loan commitment to Vistra to extend and upgrade three nuclear plants in Pennsylvania and Ohio, preserving 4 GW of power and adding 433 MW of new capacity. This deal is part of Trump's broader initiative to quadruple U.S. nuclear capacity to 400 GW by 2050. Meta has already signed a 20-year power purchase agreement with Vistra for 2,609 MW from these plants, highlighting how existing reactor owners are positioned to benefit most from the nuclear renaissance driven by AI energy demands.